# OnCo record alterome-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/alterome-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "alterome-therapeutics" ;
  schema:name "Alterome Therapeutics"@en ;
  schema:description "Alterome Therapeutics makes tablets designed to switch off one specific faulty version of a cancer-driving protein, so that healthy cells are spared. Its two medicines, for cancers driven by mutant AKT1 or mutant KRAS, are in early trials."@en ;
  schema:url <https://onco.cc/companies/alterome-therapeutics/>, <https://www.alterome.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.alterome.com/>, <https://clinicaltrials.gov/study/NCT06533059>, <https://clinicaltrials.gov/study/NCT06835569>, <https://www.alterome.com/news/> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/colorectal/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/pi3k-akt-mtor-inhibitors/>, <https://onco.cc/technologies/kras-inhibitors/> ;
  onco:targets <https://onco.cc/targets/akt/>, <https://onco.cc/targets/kras/> .